Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence

被引：6
作者：
Siegel, Abby B.
El-Serag, Hashem B.
机构：
[1] NY 10032, 622 West 168th Street, PH 14
来源：
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 2013年 / 7卷 / 06期
关键词：
hepatocellular carcinoma; prevention; statin; HEPATITIS-C VIRUS; FATTY LIVER-DISEASE; METABOLIC SYNDROME; COLORECTAL-CANCER; UNITED-STATES; RISK-FACTOR; US ADULTS; METAANALYSIS; OBESITY; MORTALITY;
D O I：
10.1586/17474124.2013.814884
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：493 / 495
页数：3
相关论文
共 50 条
  • [41] The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
    Li, Dongming
    Cao, Donghui
    Cui, Yingnan
    Sun, Yuanlin
    Jiang, Jing
    Cao, Xueyuan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
    Tsan, Yu-Tse
    Lee, Chang-Hsing
    Wang, Jung-Der
    Chen, Pau-Chung
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 623 - 630
  • [43] Is There a Role for Statins in Palliative Care for Patients Suffering from Hepatocellular Carcinoma?
    Bjorkhem-Bergman, Linda
    JOURNAL OF PALLIATIVE CARE, 2015, 31 (03) : 172 - 176
  • [44] Statins and the Colorectum: Hope for Chemoprevention?
    Baron, John A.
    CANCER PREVENTION RESEARCH, 2010, 3 (05) : 573 - 575
  • [45] Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma
    Donadon, Valter
    Balbi, Massimiliano
    Valent, Francesca
    Avogaro, Angelo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (24) : 3025 - 3032
  • [46] Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis
    Khajeh, Elias
    Aminizadeh, Ehsan
    Moghadam, Arash Dooghaie
    Ramouz, Ali
    Klotz, Rosa
    Golriz, Mohammad
    Merle, Uta
    Springfeld, Christoph
    Chang, De-Hua
    Longerich, Thomas
    Buechler, Markus W.
    Mehrabi, Arianeb
    CANCER MEDICINE, 2023, 12 (19): : 19548 - 19559
  • [47] Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View
    Tiniakos, Dina G.
    Mauricio, Joao
    Reeves, Helen L.
    ALCOHOL AND CANCER, 2018, 1032 : 55 - 69
  • [48] Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
    Kim, Gyuri
    Jang, Suk-Yong
    Han, Eugene
    Lee, Yong-ho
    Park, Se-young
    Nam, Chung Mo
    Kang, Eun Seok
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 798 - 806
  • [49] The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis
    Salomao, Marcela
    Remotti, Helen
    Vaughan, Roger
    Siegel, Abby B.
    Lefkowitch, Jay H.
    Moreira, Roger Klein
    HUMAN PATHOLOGY, 2012, 43 (05) : 737 - 746
  • [50] Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis
    Masahito Shimizu
    Takuji Tanaka
    Hisataka Moriwaki
    Seminars in Immunopathology, 2013, 35 : 191 - 202
12345